José Maria Augé

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases

José Miguel Escudero Fernández, José Maria Augé, Xavier Filella et al. · Clinical Chemistry · 2011 · 202 citations

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

Rafael Molina, José Miguel Escudero Fernández, José Maria Augé et al. · Tumor Biology · 2011 · 172 citations · Full text

Ca 125, Cancer Detection, Medicine +14

A randomized comparison ofrepeat stenting with balloon angioplasty in patients with in-stent restenosis

Fernándo Alfonso, Javier Zueco, Ángel Cequier et al. · Journal of the American College of Cardiology · 2003 · 139 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +12

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE

Rafael Molina, José Maria Augé, José Miguel Escudero Fernández et al. · Tumor Biology · 2008 · 122 citations

Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.

Rafael Molina, José Maria Augé, Xavier Filella et al. · PubMed · 2005 · 90 citations

Translational Medicine, Urology, Cyfra 21-1 +11